Today, medical imaging technologies such as X-ray and MRI machines are so ubiquitous across healthcare settings that it is difficult to imagine a life without them.
Sarepta Therapeutics has decided not to continue the development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy (DMD) therapy Exondys 51.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.